Thrombotic Thrombocytopenic Purpura: Advances in Pathophysiology, Diagnosis, and Treatment - Introduction

Seminars in Hematology

Volumn 41, Issue 1, 2004, Pages 1-3

  Lämmle, Bernhard ^a   George, James N ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MITOMYCIN C; QUININE; TICLOPIDINE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

CLINICAL FEATURE; CLINICAL TRIAL; DRUG INDUCED DISEASE; EDITORIAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0347356452     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2003.11.001     Document Type: Editorial

References (18)

1. Moschcowitz E: An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. Arch Intern Med 36:89-93, 1925
2. Amorosi EL, Ultmann JE: Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. Medicine 45:139-159, 1966
3. Bukowski RM, Hewlett JS, Harris JW, Hoffman GC, Battle JD, Silverblatt E, et al: Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura. Semin Hematol 13: 219-232, 1976
4. Byrnes JJ, Khurana M: Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 297:1386-1389, 1977
5. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, et al: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393-397, 1991
6. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, et al: Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432-1435, 1982
7. Furlan M, Robles R, Lämmle B: Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87:4223-4234, 1996
8. Tsai H-M: Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87:4235-4244, 1996
9. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al: Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. N Engl J Med 339:1578-1584, 1998
10. Tsai H-M, Lian ECY: Antibodies to von-Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585-1594, 1998
11. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K: Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276:41059-41063, 2001
12. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al: Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488-494, 2001
13. Moake JL: Thrombotic microangiopathies. N Engl J Med 347:589-600, 2002
14. George JN, Vesely SK: Thrombotic thrombocytopenic purpura: From the bench to the bedside, but not yet to the community (editorial). Ann Intern Med 138:152-153, 2003
15. Furlan M, Lämmle B: Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: The role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol 14:437-454, 2001
16. Vesely SK, George JN, Lämmle B, Studt J-D, Alberio L, El-Harake MA, et al: ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 101:60-68, 2003
17. Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R: Hamolytisch-uramische Syndrome: Bilaterale Nierenrindennekrosen bei akuten erworbenen hamolytischen Anamien. Schweiz Med Wochenschr 85:905-909, 1955
18. Kojouri K, Vesely S, George JN: Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes. Ann Intern Med 135:1047-1051, 2001